Evercore ISI Group Maintains Outperform on Vera Therapeutics, Raises Price Target to $97

Benzinga · 1d ago
Evercore ISI Group analyst Gavin Clark-Gartner maintains Vera Therapeutics (NASDAQ:VERA) with a Outperform and raises the price target from $75 to $97.